Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Real-Life Safety and Effectiveness of Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis.

Burgel PR, Munck A, Durieu I, Chiron R, Mely L, Prevotat A, Murris-Espin M, Porzio M, Abely M, Reix P, Marguet C, Macey J, Sermet-Gaudelus I, Corvol H, Bui S, Lemonnier L, Dehillotte C, Da Silva J, Paillasseur JL, Hubert D; French Cystic Fibrosis Reference Network Study Group.

Am J Respir Crit Care Med. 2020 Jan 15;201(2):188-197. doi: 10.1164/rccm.201906-1227OC.

PMID:
31601120
2.

Dynamic changes of DNA methylation and lung disease in cystic fibrosis: lessons from a monogenic disease.

Magalhães M, Tost J, Pineau F, Rivals I, Busato F, Alary N, Mely L, Leroy S, Murris M, Caimmi D, Claustres M, Chiron R, De Sario A.

Epigenomics. 2018 Aug;10(8):1131-1145. doi: 10.2217/epi-2018-0005. Epub 2018 Jul 27.

PMID:
30052057
3.

Overall and differentiated sensory responses to cardiopulmonary exercise test in patients with cystic fibrosis: kinetics and ability to predict peak oxygen uptake.

Gruet M, Mely L, Vallier JM.

Eur J Appl Physiol. 2018 Sep;118(9):2007-2019. doi: 10.1007/s00421-018-3923-y. Epub 2018 Jul 9.

PMID:
29987367
4.

Eosinophilic granulomatosis with polyangiitis in children: Data from the French RespiRare® cohort.

Fina A, Dubus JC, Tran A, Derelle J, Reix P, Fayon M, Couderc L, Donnou MD, Pagnier A, Blanchon S, Faure N, Mely L, Albertini M, de Blic J, Giovannini-Chami L.

Pediatr Pulmonol. 2018 Dec;53(12):1640-1650. doi: 10.1002/ppul.24089. Epub 2018 Jun 26.

PMID:
29943913
5.

Retrospective observational study of French patients with cystic fibrosis and a Gly551Asp-CFTR mutation after 1 and 2years of treatment with ivacaftor in a real-world setting.

Hubert D, Dehillotte C, Munck A, David V, Baek J, Mely L, Dominique S, Ramel S, Danner Boucher I, Lefeuvre S, Reynaud Q, Colomb-Jung V, Bakouboula P, Lemonnier L.

J Cyst Fibros. 2018 Jan;17(1):89-95. doi: 10.1016/j.jcf.2017.07.001. Epub 2017 Jul 12.

PMID:
28711222
6.

DNA methylation at modifier genes of lung disease severity is altered in cystic fibrosis.

Magalhães M, Rivals I, Claustres M, Varilh J, Thomasset M, Bergougnoux A, Mely L, Leroy S, Corvol H, Guillot L, Murris M, Beyne E, Caimmi D, Vachier I, Chiron R, De Sario A.

Clin Epigenetics. 2017 Feb 14;9:19. doi: 10.1186/s13148-016-0300-8. eCollection 2017.

7.
8.

Case series of omalizumab for allergic bronchopulmonary aspergillosis in cystic fibrosis patients.

Nové-Josserand R, Grard S, Auzou L, Reix P, Murris-Espin M, Brémont F, Mammar B, Mely L, Hubert D, Durieu I, Burgel PR.

Pediatr Pulmonol. 2017 Feb;52(2):190-197. doi: 10.1002/ppul.23612. Epub 2016 Oct 7.

PMID:
27717223
9.

Long-Term Rasamsonia argillacea Complex Species Colonization Revealed by PCR Amplification of Repetitive DNA Sequences in Cystic Fibrosis Patients.

Mouhajir A, Matray O, Giraud S, Mély L, Marguet C, Sermet-Gaudelus I, Le Gal S, Labbé F, Person C, Troussier F, Ballet JJ, Gargala G, Zouhair R, Bougnoux ME, Bouchara JP, Favennec L.

J Clin Microbiol. 2016 Nov;54(11):2804-2812. Epub 2016 Sep 7.

10.

Absence of calf muscle metabolism alterations in active cystic fibrosis adults with mild to moderate lung disease.

Decorte N, Gruet M, Camara B, Quetant S, Mely L, Vallier JM, Verges S, Wuyam B.

J Cyst Fibros. 2017 Jan;16(1):98-106. doi: 10.1016/j.jcf.2016.05.010. Epub 2016 Jun 15.

11.

Physiological Responses of the Modified Shuttle Test in Adults With Cystic Fibrosis.

Vallier JM, Rouissi M, Mely L, Gruet M.

J Cardiopulm Rehabil Prev. 2016 Jul-Aug;36(4):288-92. doi: 10.1097/HCR.0000000000000181.

PMID:
27182761
12.

Epidemic spread of Pandoraea pulmonicola in a cystic fibrosis center.

Degand N, Lotte R, Decondé Le Butor C, Segonds C, Thouverez M, Ferroni A, Vallier C, Mély L, Carrère J.

BMC Infect Dis. 2015 Dec 26;15:583. doi: 10.1186/s12879-015-1327-8.

13.

Skeletal muscle contractility and fatigability in adults with cystic fibrosis.

Gruet M, Decorte N, Mely L, Vallier JM, Camara B, Quetant S, Wuyam B, Verges S.

J Cyst Fibros. 2016 Jan;15(1):e1-8. doi: 10.1016/j.jcf.2015.05.004. Epub 2015 May 29.

14.

Pandoraea pulmonicola chronic colonization in a cystic fibrosis patient, France.

Kokcha S, Bittar F, Reynaud-Gaubert M, Mely L, Gomez C, Gaubert JY, Thomas P, Rolain JM.

New Microbes New Infect. 2013 Nov;1(2):27-9. doi: 10.1002/2052-2975.16. Epub 2013 Sep 30.

15.

ISPa46, a novel insertion sequence in the oprD porin gene of an imipenem-resistant Pseudomonas aeruginosa isolate from a cystic fibrosis patient in Marseille, France.

Diene SM, L'homme T, Bellulo S, Stremler N, Dubus JC, Mely L, Leroy S, Degand N, Rolain JM.

Int J Antimicrob Agents. 2013 Sep;42(3):268-71. doi: 10.1016/j.ijantimicag.2013.06.001. Epub 2013 Jul 20.

PMID:
23880169
16.

Identification of a novel duplication CFTRdup2 and functional impact of large rearrangements identified in the CFTR gene.

Taulan M, Viart V, Theze C, Guittard C, Altieri JP, Templin C, Mely L, Claustres M, des Georges M.

Gene. 2012 Jun 1;500(2):194-8. doi: 10.1016/j.gene.2012.03.043. Epub 2012 Mar 29.

PMID:
22484595
17.

Neuromuscular fatigue after maximal exercise in patients with cystic fibrosis.

Vallier JM, Gruet M, Mely L, Pensini M, Brisswalter J.

J Electromyogr Kinesiol. 2011 Apr;21(2):242-8. doi: 10.1016/j.jelekin.2010.10.010.

PMID:
21078561
18.

Unusual Aspergillus species in patients with cystic fibrosis.

Symoens F, Haase G, Pihet M, Carrere J, Beguin H, Degand N, Mely L, Bouchara JP.

Med Mycol. 2010 Nov;48 Suppl 1:S10-6. doi: 10.3109/13693786.2010.501345.

PMID:
21067321
19.

Association of three different congenital malformations in a same pulmonary lobe in a 5-year-old girl.

Carsin A, Mely L, Chrestian MA, Devred P, de Lagausie P, Guys JM, Dubus JC.

Pediatr Pulmonol. 2010 Aug;45(8):832-5. doi: 10.1002/ppul.21068.

PMID:
20652995
20.

Geosmithia argillacea: an emerging pathogen in patients with cystic fibrosis.

Giraud S, Pihet M, Razafimandimby B, Carrère J, Degand N, Mely L, Favennec L, Dannaoui E, Bouchara JP, Calenda A.

J Clin Microbiol. 2010 Jul;48(7):2381-6. doi: 10.1128/JCM.00047-10. Epub 2010 May 12.

21.

[Physical activity and exercise training for patients with cystic fibrosis].

Karila C, Ravilly S, Gauthier R, Tardif C, Neveu H, Maire J, Ramel S, Cracowski C, Legallais P, Foure H, Halm AM, Saugier J, Bordas G, Loire N, Kirszenbaum M, Dassonville J, Mely L, Wuyam B, Giovannetti P, Ouksel H, Ellaffi M, Denjean A; groupe de travail de la Société francaise de la mucoviscidose.

Rev Mal Respir. 2010 Apr;27(4):301-13. doi: 10.1016/j.rmr.2010.02.012. Epub 2010 Mar 30. Review. French.

PMID:
20403541
22.

Use of the peak heart rate reached during six-minute walk test to predict individualized training intensity in patients with cystic fibrosis: validity and reliability.

Gruet M, Brisswalter J, Mely L, Vallier JM.

Arch Phys Med Rehabil. 2010 Apr;91(4):602-7. doi: 10.1016/j.apmr.2009.12.008.

PMID:
20382294
23.

Clinical utility of the oxygen uptake efficiency slope in cystic fibrosis patients.

Gruet M, Brisswalter J, Mely L, Vallier JM.

J Cyst Fibros. 2010 Sep;9(5):307-13. doi: 10.1016/j.jcf.2010.03.003. Epub 2010 Mar 31.

24.

Non-classic cystic fibrosis associated with D1152H CFTR mutation.

Burgel PR, Fajac I, Hubert D, Grenet D, Stremler N, Roussey M, Siret D, Languepin J, Mely L, Fanton A, Labbé A, Domblides P, Vic P, Dagorne M, Reynaud-Gaubert M, Counil F, Varaigne F, Bienvenu T, Bellis G, Dusser D.

Clin Genet. 2010 Apr;77(4):355-64. doi: 10.1111/j.1399-0004.2009.01294.x. Epub 2009 Oct 15.

PMID:
19843100
25.

Pharmacokinetics and safety of tobramycin administered by the PARI eFlow rapid nebulizer in cystic fibrosis.

Hubert D, Leroy S, Nove-Josserand R, Murris-Espin M, Mely L, Dominique S, Delaisi B, Kho P, Kovarik JM.

J Cyst Fibros. 2009 Sep;8(5):332-7. doi: 10.1016/j.jcf.2009.07.001. Epub 2009 Aug 3.

26.

Long term reliability of EMG measurements in adults with cystic fibrosis.

Gruet M, Vallier JM, Mely L, Brisswalter J.

J Electromyogr Kinesiol. 2010 Apr;20(2):305-12. doi: 10.1016/j.jelekin.2009.05.001. Epub 2009 Jun 17.

PMID:
19539501
27.

[Neuromuscular function in patients with cystic fibrosis].

Mely L, Bernard C, Plantier D, Pensini M, Brisswalter J, Vallier JM.

Rev Mal Respir. 2007 Nov;24(9):1117-23. French.

PMID:
18176388
28.

Use of lidocaine-prilocaine patch for the mantoux test: Influence on pain and reading.

Dubus JC, Mely L, Lanteaume A.

Int J Pharm. 2006 Dec 11;327(1-2):78-80. Epub 2006 Jul 25.

PMID:
16959450
29.

[Cystic intrathoracic hemolymphangioma: a rare differential diagnosis of acute bronchiolitis in an infant].

Bosdure E, Mates M, Mely L, Guys JM, Devred P, Dubus JC.

Arch Pediatr. 2005 Feb;12(2):168-72. French.

PMID:
15694542
30.

French experience of silicone tracheobronchial stenting in children.

Fayon M, Donato L, de Blic J, Labbé A, Becmeur F, Mely L, Dutau H.

Pediatr Pulmonol. 2005 Jan;39(1):21-7.

PMID:
15532081
31.

Association of HbS and a new low oxygen affinity variant, Hb Canebière, [beta102(G4)Asn->Lys] in a healthy child.

Thuret I, Mely L, Kister J, Kiger L, Merono F, Badier M, Badens C.

Haematologica. 2004 Sep;89(9):ECR31. No abstract available.

32.

[Isolated agenesia of pulmonary artery].

Boudard I, Mely L, Labbé A, Bellon G, Chabrol B, Dubus JC.

Arch Pediatr. 2004 Sep;11(9):1078-82. French.

PMID:
15350999
33.

Cough after inhalation of corticosteroids delivered from spacer devices in children with asthma.

Dubus JC, Mély L, Huiart L, Marguet C, Le Roux P; Réseau de Recherche Clinique en Pneumologie Pédiatrique.

Fundam Clin Pharmacol. 2003 Oct;17(5):627-31.

PMID:
14703724
34.

[Inhalers and nebulizers in the children].

David V, Mély L, Siret D, Dubus JC.

Arch Pediatr. 2002 Aug;9 Suppl 3:415s-421s. Review. French.

PMID:
12205818
35.

[The beta-2-agonists in asthma in infants and young children].

Dubus JC, Mély L, Stremler-Lebel N, Chabrol B.

Arch Pediatr. 2002 Aug;9 Suppl 3:384s-389s. Review. French.

PMID:
12205813
36.

Local side-effects of inhaled corticosteroids in asthmatic children: influence of drug, dose, age, and device.

Dubus JC, Marguet C, Deschildre A, Mely L, Le Roux P, Brouard J, Huiart L; Réseau de Recherche Clinique en Pneumonologie Pédiatrique.

Allergy. 2001 Oct;56(10):944-8.

PMID:
11576072
37.

Venom immunotherapy induces monocyte activation.

Magnan A, Marin V, Mély L, Birnbaum J, Romanet S, Bongrand P, Vervloet D.

Clin Exp Allergy. 2001 Aug;31(8):1303-9.

PMID:
11529902
38.

Cytokines, from atopy to asthma: the Th2 dogma revisited.

Magnan A, Boniface S, Mély L, Romanet S, Mamessier E, Vervloet D.

Cell Mol Biol (Noisy-le-grand). 2001 Jun;47(4):679-87. Review.

PMID:
11502075
39.

Flow cytometric microsphere-based immunoassay: analysis of secreted cytokines in whole-blood samples from asthmatics.

Camilla C, Mély L, Magnan A, Casano B, Prato S, Debono S, Montero F, Defoort JP, Martin M, Fert V.

Clin Diagn Lab Immunol. 2001 Jul;8(4):776-84.

40.

[Neurologic complications associated with antalgic and anti-inflammatory agents].

Chabrol B, Mely L, Lethel V, Hugonenc C, Dubus JC, Mancini J.

Arch Pediatr. 2001 May;8 Suppl 2:329s-331s. French. No abstract available.

PMID:
11394105
41.

[Virus and respiratory allergy in children].

Dubus JC, Bosdure E, Mates M, Mely L.

Allerg Immunol (Paris). 2001 Feb;33(2):78-81. Review. French.

PMID:
11339058
42.

Relationships between natural T cells, atopy, IgE levels, and IL-4 production.

Magnan A, Mély L, Prato S, Vervloet D, Romagné F, Camilla C, Necker A, Casano B, Montero-Jullian F, Fert V, Malissen B, Bongrand P.

Allergy. 2000 Mar;55(3):286-90.

PMID:
10753021
43.

Assessment of the Th1/Th2 paradigm in whole blood in atopy and asthma. Increased IFN-gamma-producing CD8(+) T cells in asthma.

Magnan AO, Mély LG, Camilla CA, Badier MM, Montero-Julian FA, Guillot CM, Casano BB, Prato SJ, Fert V, Bongrand P, Vervloet D.

Am J Respir Crit Care Med. 2000 Jun;161(6):1790-6.

PMID:
10852746
44.

[Acute asthmatic crisis in children].

Dubus JC, Bodiou AC, Buttin C, Jouglet T, Stremler N, Mély L.

Arch Pediatr. 2000 Mar;7 Suppl 1:27S-32S. Review. French.

PMID:
10793944
45.

[Modes of administration of inhaled corticosteroids in mild to moderate persistent asthma].

Pinet C, Nieves A, Mely L, Magnan A, Vervloet D.

Rev Mal Respir. 1999 Nov;16(5):856-60. Review. French.

PMID:
10612162
46.

[Influence of the inhaler device on bronchodilatation in the asthmatic child].

Dubus JC, Stremler N, Mely L, Bruguerolle B.

Rev Mal Respir. 1997 Jun;14(3):193-8. French.

PMID:
9411596
47.

Acute presentation of congenital diaphragmatic hernia past the neonatal period: a life threatening emergency.

Paut O, Mély L, Viard L, Silicani MA, Guys JM, Camboulives J.

Can J Anaesth. 1996 Jun;43(6):621-5.

PMID:
8773870

Supplemental Content

Support Center